Central effects of glucagon-like peptide-1 on cold-restraint stress-induced gastric mucosal lesions

Turkish Journal of Gastroenterology

Volumn 18, Issue 3, 2007, Pages 150-156

  Isbil Buyukcoskun, Naciye ^a   Güleç, Güldal ^a   Çam Etöz, Betül ^a   Özlük, Kasim ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Atropine; CGRP (8 37); Exendin (9 39); Gastroprotection; Glucagon like peptide 1; Indomethacin; Intracerebroventricular; L NAME

Indexed keywords

ATROPINE; CALCITONIN GENE RELATED PEPTIDE; ETHER; EXENDIN 9 39; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAGE; CANNULA; COLD STRESS; DECAPITATION; DRUG EFFECT; DRUG INHIBITION; INJECTION; MALE; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE; STOMACH; STOMACH MUCOSA LESION; STOMACH PROTECTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATROPINE; CALCITONIN GENE-RELATED PEPTIDE; COLD TEMPERATURE; ENZYME INHIBITORS; GASTRIC MUCOSA; GLUCAGON-LIKE PEPTIDE 1; INCRETINS; INDOMETHACIN; INJECTIONS; MALE; NG-NITROARGININE METHYL ESTER; PARASYMPATHOLYTICS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RESTRAINT, PHYSICAL; STRESS, PHYSIOLOGICAL;

EID: 43549098794     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Haglund U. Stress ulcer. Scand J Gastroenterol 1990; 25: 27-33.
2. Holzer P. Gastroduodenal mucosal defense. Curr Opin Gastroenterol 2000; 16: 469-78.
3. Goldman H, Rosof CB. Pathogenesis of acute gastric stress ulcer. Am J Pathol 1968; 52: 227-43.
4. Guth PH. Gastric blood flow in restraint stress. Am J Dig Dis 1972; 17: 807-13.
5. Pawlik M, Ptak A, Pajdo R, et al. Sensory nerves and calcitonin gene related peptide in the effect of ischemic preconditioning on acute and chronic gastric lesions induced by ischemia-reperfusion. J Physiol Pharmacol 2001; 52: 569-81.
6. Gustaw P, Pawlik WW, Czarnobilski K, et al. Nitric oxide is involved in the mediation of gastric blood flow and tissue oxygenation. J Physiol Pharmacol 1994; 45: 361-8.
7. Whittle BJR, Lopez-Bolmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interaction with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990; 99: 607-11.
8. Dembinski A, Warzecha Z, Ceranowicz P, et al. Role of capsaicin-sensitive nerves and histamine H1, H2, and H3 receptors in the gastroprotective effect of histamine against stress ulcers in rats. Eur J Pharmacol 2005; 508: 211-21.
9. Brzozowski T, Konturek PC, Konturek SJ. Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage. Regul Pept 2004; 120: 39-51.
10. Samonina GE, Kopylova GN, Lukjanzeva GV, et al. Antiulcer effects of amylin: a review. Pathophysiology 2004; 11: 1-6.
11. Kreymann B, Ghatei MA, Burnet P, et al. Characterization of glucagon-like peptide-1 (7-36) amide in the rat hypothalamus. Brain Res 1989; 502: 325-31.
12. Mojsov S, Heinrich G, Wilson IB, et al. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem 1986; 261: 11880-9.
13. Göke R, Fehmann HC, Linn T, et al. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cells. J Biol Chem 1993; 268: 19650-5.
14. Daniel EE, Anvari M, Fox-Threlkeld JE, et al. Local, exendin-(9-39)- insensitive, site of action of GLP-1 in canine ileum. Am J Physiol 2002; 283: 595-602.
15. Jin SL, Han VK, Simmons JG, et al. Distribution of glucagon-like peptide-1 (GLP-1), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 1988; 271: 519-32.
16. Larsen PJ, Tang-Christensen M, Holst JJ, et al. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 1997; 77: 257-70.
17. Merchenthaler I, Lane M, Shughrue P. Distribution of prepro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 1999; 403: 261-80.
18. Goke R, Larsen PJ, Mikkelsen JD, et al. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 1995; 7: 2294-300.
19. Shimizu I, Hirota M, Obhoshi C, et al. Identification and localization of glucagon-like peptide-1 and its receptor in rat brain. Endocrinology 1987; 121: 1076-82.
20. Drucker DJ, Asa S. Glucagon gene expression in vertebrate brain. J Biol Chem 1988; 263: 13475-8.
21. Zueco JA, Esquifino AI, Chowen JA, et al. Coexpression of glucagon-like peptide-1 (GLP-1) receptor, vasopressin, and oxytocin mRNAs in neurons of the rat hypothalamic supraoptic and paraventricular nuclei: effect of GLP-1 (7-36) amide on vasopressin and oxytocin release. J Neurochem 1999; 72: 10-6.
22. Rowland NE, Crews EC, Gentry RM. Comparison of Fos induced in rat brain by GLP-1 and amylin. Regul Pept 1997; 71: 171-4.
23. Turton MD, O'Shea D, Gunn I, et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1998; 379: 69-72.
24. Donahey JC, van Dijk G, Woods SC, et al. Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats. Brain Res 1998; 779: 75-83.
25. Imeryuz N, Yegen BC, Bozkurt A, et al. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol 1997; 273: 920-7.
26. Tang-Christensen M, Larsen PJ, Goke R, et al. Brain GLP-1 (7-36) amide receptors play a major role in regulation of food and water intake. Am J Physiol 1996; 271: 848-56.
27. Thiele TE, van Dijk G, Campfield LA, et al. Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am J Physiol 1997; 272: 726-30.
28. Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev 1999; 20: 876-913.
29. Isbil-Buyukcoskun N, Gulec G. Effects of centrally injected GLP-1 in various experimental models of gastric mucosal damage. Peptides 2004; 25: 1179-83.
30. Drago F, Grassi M, Genazzani AA. Neuromediators in aging and gastric mucosal injury. J Physiol Paris 1993; 87: 379-83.
31. Buyukcoskun NI, Ozluk K. Role of intracerebroventricular vasopressin in the development of stress-induced gastric lesions in rats. Physiol Res 1999; 48: 451-5.
32. Isbil-Buyukcoskun N, Gulec G. Investigation of the mechanisms involved in the central effects of glucagon-like peptide-1 on ethanol-induced gastric mucosal lesions. Regul Pept 2005; 128: 57-62.
33. Cho CH, Koo MWL, Garg GP, et al. Stress-induced gastric ulceration: its aetiology and clinical implications. Scand J Gastroenterol 1992; 27: 257-62.
34. Rinaman L. Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus. Am J Physiol 1999; 277: 582-90.
35. Gülpinar MA, Bozkurt A, Coskun T, et al. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats. Am J Physiol Gastrointest Liver Physiol 2000; 278: 924-9.
36. Sarkar S, Fekete C, Legradi G, et al. Glucagon-like peptide-1 amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Brain Res 2003; 985: 163-8.
37. MacLusky NJ, Cook S, Scrocchi L, et al. Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology 2000; 141: 752-62.
38. Gunion MW, Tache Y. Gastric mucosal damage inhibited by intraventromedial hypothalamic corticotropin releasing factor. Abstr Soc Neurosci 1986; 12: 644-51.
39. Orlando RC, Hernandez DE, Nemerof CB, et al. Role of the autonomic nervous system in neurotensin's cytoprotective effect for gastric stress ulcers in rats. Ann NY Acad Sci 1982; 400: 432-7.
40. Hernandez DE, Adcock JW, Nemerof CB, et al. The role of the adrenal gland in cytoprotection against stress-induced gastric ulcers in rats. J Neurol Res 1984; 11: 193-201.
41. Wettergren A, Wqjdemann M, Holst JJ. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. Am J Physiol 1998; 275: 984-92.
42. Barragan JM, Rodriguez RE, Eng J, et al. Interaction of exendin-(9-39) with the effects of glucagon-like peptide-1-(7-36) amide and of exendin-4 on arterial blood pressure and heart rate in rats. Regul Pept 1996; 67: 63-8.
43. Eissele R, Bothe-Sandfort E, Göke B, et al. Rat gastric somatostatin and gastrin release: interaction of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide. Life Sci 1994; 55: 629-34.
44. Whitcomb DC, Taylor IL. A new twist in the brain-gut axis. Am J Med Sci 1992; 304: 334-8.
45. Giralt M, Vergara P. Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat. Regul Pept 1998; 74: 19-25.
46. Dray A. Inflammatory mediators of pain. Br J Anaesth 1995; 75: 125-31.
47. Holzer P, Guth PH. Neuropeptide control of rat gastric mucosal blood flow: increase by calcitonin gene-related peptide and vasoactive intestinal polypeptide, but not substance P and neurokinin A. Circ Res 1991; 12: 25-31.
48. Auguste LJ, Angus L, Stein TA, et al. Starvation and mucosal prostaglandin-E2 in gastric stress ulceration. Crit Care Med 1988; 16: 610-1.
49. Harada N, Okajima K, Uchiba M, et al. Contribution of capsaicin-sensitive sensory neurons to stress-induced increase in gastric tissue levels of prostaglandins in rats. Am J Physiol 2003; 285: 1214-24.
50. Harada N, Okajima K, Murakami K, et al. Gastric prostacyclin (PGI2) prevents stress-induced gastric mucosal injury in rats primarily by inhibiting leukocyte activation. Prostaglandins Other Lipid Mediat 1999; 57: 291-303.
51. Barragan JM, Eng J, Rodriguez R, et al. Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. Am J Physiol 1999; 277: 784-91.
52. Isbil-Buyukcoskun N, Gulec G. Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin. Regul Pept 2004; 118: 33-8.